Biotest AG
XHAM:BIO
Biotest AG
XHAM:BIO
Price:
41
EUR
2.5%
Market Closed
Market Cap:
€1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Biotest AG
XHAM:BIO
|
DE |
|
H
|
HEICO Corp
F:HC1
|
US |
|
Note AB (publ)
F:NQA
|
SE |
|
Nippn Corp
TSE:2001
|
JP |
|
SPS Commerce Inc
F:S86
|
US |
|
I
|
Iridium Communications Inc
F:6IC
|
US |
|
T
|
TX Group AG
OTC:TDAAF
|
CH |
|
H
|
Hudbay Minerals Inc
SWB:OCKA
|
CA |
|
A
|
Ardelyx Inc
SWB:41X
|
US |
|
T
|
Tencent Holdings Ltd
XMUN:NNND
|
CN |
|
F
|
Firefinch Ltd
F:N9F
|
AU |
|
Tikehau Capital SCA
OTC:TKKHF
|
FR |
|
W
|
Wilmar International Ltd
F:RTHA
|
SG |
|
Fujitsu Ltd
F:FUJA
|
JP |
|
W
|
Weichai Power Co Ltd
OTC:WEICF
|
CN |
|
H
|
Home Depot Inc
XBER:HDI
|
US |
|
O
|
Orion Oyj
DUS:OFK
|
FI |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIO's stock price target?
Not Available
BIO does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Biotest AG?
Projected CAGR
-1%
-1%
Over the last 8 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 1 year is -1%.
What is the Operating Income forecast for Biotest AG?
Projected CAGR
25%
25%
Over the last 8 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 1 year is 25%.
What is the Net Income forecast for Biotest AG?
Projected CAGR
121%
121%
The compound annual growth rate for Net Income over the next 1 year is 121%.
